Conditions: Asthma; Chronic Obstructive Pulmonary Disease
Interventions: Drug: Fluticasone furoate (200 mcg)/GW642444 (25mcg) combination; Drug: Fluticasone furoate (400 mcg)/GW642444 (50mcg) combination; Drug: Placebo Inhaler; Drug: Moxifloxacin 400mg; Drug: Moxifloxacin placebo
Sponsor: GlaxoSmithKline
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days